23andME
23andMe to offer genetic reports on diabetes
March 11, 2019Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics
Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …
Widening the focus on innovations in cancer treatment
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma
Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
GSK forges $300m partnership with 23andMe to boost preclinical R&D
July 26, 2018Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma
In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
FDA authorises first direct-to-consumer test for BRCA mutations, with caveats
March 6, 2018Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma
The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …
23andMe raises $250m in financing, research points towards its future
September 13, 2017Research and Development, Sales and Marketing 23andME, biotech, drugs, pharma, pharmaceutical
23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …
Genes found to play an important role in empathy
June 8, 2017Research and Development 23andME, University of Cambridge
A recent study, conducted by the University of Cambridge, has found that DNA plays a part in determining an individual’s …
Furore over DNA testing company’s licensing of consumers’ data
May 26, 2017Medical Communications 23andME, Ancestry, DNA, DNA testing, genetic information
A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …
23andMe’s apps to aid genetic research for Apple’s ResearchKit
March 22, 2016Manufacturing and Production, Research and Development 23andME, Apple, genetics, research
Privately-held 23andMe has announced a new module for Apple’s (Nasdaq: AAPL) open source ResearchKit software framework that allows scientists to …
23andMe targets $150 million for drug development
July 8, 2015Research and Development 23andME, DNA, DNA testing, genetics, venture capital
The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
Searching for new biotech solutions
June 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Emily Drabant Conley, google
For pharma, the elevator pitch for 23andMe is an intriguing prospect. It has the largest genetic database in the world, …
Bioinformatics pioneer joins 23andMe from Genentech
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Genentech, Robert Gentleman
California-based personal genetics firm 23andMe has appointed Robert Gentleman to be its vice president of computational biology. The company is …
23andMe to move into drug development
March 16, 2015Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, Pfizer, google
The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …
23andMe appoints privacy officer
March 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, kate black
US genetics testing firm 23andMe has appointed Kate Black as its privacy officer and corporate counsel.
Genentech and Human Longevity ink genomics deal
January 19, 2015Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity
Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …
Genentech makes $10m gene testing outlay
January 8, 2015Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, MHRA, Pfizer, Roche
Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …
Latest content
FibroFind appoints Lee Borthwick as CEO
